echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > JAMA Sub-Journal: Comparison of efficacy and safety of first-line chemotherapy regimens for advanced neuroendocrine cancer!

    JAMA Sub-Journal: Comparison of efficacy and safety of first-line chemotherapy regimens for advanced neuroendocrine cancer!

    • Last Update: 2022-09-08
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    *For medical professional reading reference only

    1 minute a day, give you professional "talks" in the tumor circle! (If you need the original text of the literature, you can add Xiaobian WeChat yxj_oncology to get it)

     

    1

    JAMA sub-journal: Etoposide combined with cisplatin and irinotecan combined with cisplatin are both first-line treatment options for the treatment of advanced neuroendocrine cancer, but the incidence of adverse reactions of the former may be higher


    ▎Clinical problems:






    4.


    Follow the column



    Subscribe to the column and read a new top issue every day! 

    Download the Doctor Station App and subscribe anytime, anywhere~


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.